Zurueck zur Suche

Reporte zur Charge UJ901AC

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OH 2 NY 1 MI 1 IN 1 NC 1

VAERS 2465406

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ901AC

moderat
Staat
OH
Alter
89,0
Geschlecht
F
Eingang
30.09.2022
Impfdatum
17.09.2022
Beginn
17.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Dizziness Feeling cold Hypotension

Symptomtext

patient with hypotension, dizziness, cold feeling, joint pain and light headed

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypotension
Hospital-Tage
-
Labordaten
evaluation in office
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2536133

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj901ac

mild
Staat
NY
Alter
79,0
Geschlecht
F
Eingang
18.12.2022
Impfdatum
-
Beginn
13.12.2022
Tage bis Beginn
-
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site rash

Symptomtext

patient called on 12/15/22 saying she developed a circular rash on the injection site 2 days after receiving flu shot (12/13/22). Advised her to take Benadryl and check with her doctor if its not resolved. Followed up with her on 12/18/22 and she said the rash has not gotten better since she took Benadryl for 3 days but there's no sign of progression. She said she will see her doctor.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site rash
Hospital-Tage
-
Labordaten
na
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2535123

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ901AC

mild
Staat
OH
Alter
72,0
Geschlecht
F
Eingang
16.12.2022
Impfdatum
13.09.2022
Beginn
19.11.2022
Tage bis Beginn
67,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
COVID-19 Cough Diarrhoea Discharge Ear pain Influenza A virus test negative Influenza B virus test Middle ear effusion Myalgia Nausea Oropharyngeal pain Pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

Cough, sneezing, sniffling, body aches, drainage, congestion, throat pain, ear pain, LOOSE bowels/diarrhea(continued for 3 weeks; controlled by BRAT diet, Imodium, Pepto-Bismol), rhinorrhea, nausea, myalgias, meddle ear effusion both ears, Prescribed Molnupiravir, Isolated 10 days (no work for 15 days), mostly resolved by 12/12/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
11/21/2022 RT-PCR or equivalent (Roche Molecular Systems, Inc. RMS_EUA) Positive results for Covid19 (Sars-CoC2) 11/21/2022 RT-PCR included INFLUENZA A & B Negative results
Aktuelle Erkrankungen
-
Vorgeschichte
Hyperlipidemia, Essential Hypertension, Pre-diabetes, Essential Tremor, GERD
Andere Medikamente
Medications list Prescribed Aspirin 81 mg daily Pantoprazole DR 20 mg tab- take 40 mg daily Propranolol ER 60 mg - once daily Pravastatin 40 mg, daily Azelastine 0.1 % nasal spray 1 or 2 sprays, twice daily *Premarin cream 1/4 applicato
Allergien
Topiramate, Venlafaxine Analogues, Sertraline HCL, Duloxetine
Vorherige Impfungen
-

VAERS 2510628

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj901ac

gering
Staat
MI
Alter
87,0
Geschlecht
M
Eingang
17.11.2022
Impfdatum
16.11.2022
Beginn
16.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Blood pressure increased

Symptomtext

patients blood pressure started rising right after the injection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blood pressure increased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464483

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge Uj901AC

gering
Staat
IN
Alter
74,0
Geschlecht
M
Eingang
29.09.2022
Impfdatum
29.09.2022
Beginn
29.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect product formulation administered

Symptomtext

Covid Bivalent booster given as primary dose

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
hyperlipidemia, hypertension, diverticulosis, glaucoma, scoliosis
Andere Medikamente
amLODIPine (NORVASC) 10 MG tablet Take 5 mg by mouth daily. Take one half tablet by mouth every day cholecalciferol 25 mcg (1,000 unit) Take 25 mcg by mouth 2 (two) times daily. dorzolamide (TRUSOPT) 2 % ophthalmic solution Place 1 drop int
Allergien
NKA
Vorherige Impfungen
-

VAERS 2450457

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ901AC

gering
Staat
NC
Alter
4,0
Geschlecht
F
Eingang
17.09.2022
Impfdatum
09.09.2022
Beginn
09.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

FLUZONE HIGH DOSE was administered accidentally with no reported adverse event; Initial information received on 09-Sep-2022 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 4 years old female patient to whom influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent]was administered accidentally with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP) , MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) and COVID-19 VACCINE (COVID-19 VACCINE) for Prophylactic vaccination. On 09-Sep-2022, the patient administered 0.7ml once (1x) dose of suspect influenza quadrival A-B high dose HV vaccine (lot UJ901AC and Expiration Date :30-Jun-2023) via intramuscular route in the left thigh for immunization accidentally with no reported adverse event (product administered to patient of inappropriate age) (latency: same day). The physician prescribed FLUZONE QUAD for the patient. However, another nurse in the practice accidentally "grabbed the wrong dose" and administered the FLUZONE HIGH DOSE instead. The patient was retained in the office for 20 minutes following the administration with no noted issues. Action taken : not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
DTAP; MMR; COVID-19 VACCINE
Allergien
-
Vorherige Impfungen
-